Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Contact

Phone: (202) 588-1000

Press Release

Report: For 20 Top-Selling Drugs, Big Pharma Made Far More From U.S. Sales Than From the Rest of the World Combined

Medicare drug negotiation would help end disparities.
WASHINGTON -

U.S. sales of the 20 top-selling drugs totaled $101.1 billion in 2020, while sales of these drugs to the rest of the world totaled only $57 billion, highlighting how Americans massively overpay for drugs, a new Public Citizen report found.

Some drugs saw greater disparities than others. For example, AbbVie earned $16,112,000,000 from U.S. sales of the autoimmune drug Humira, compared to $3,720,000,000 from international sales, or more than four times as much. For 17 of the 20 top-selling drugs worldwide, Big Pharma made more from U.S. sales than from sales to all other countries combined, and for 11 of the 20, U.S. sales revenue was double that of the rest of the world or more, the report found.

Additionally, 11 of the 13 pharmaceutical companies selling these top drugs made more money in the U.S. from these drugs than they did in the rest of the world combined.

The analysis offers a glimpse of how much these businesses benefit from the American health care system overpaying for drugs. The U.S. is one of the only high-income countries not to negotiate the price of drugs. Granting Medicare the authority to push back against pharmaceutical company profiteering would mean an end to decades of overpaying for medicines and would save the U.S. billions of dollars.

“This eye-popping rip off Big Pharma is getting away with is an insult to the American people,” said Rick Claypool, a Public Citizen research director and co-author of the report. “Empowering Medicare to push back against inflated drug prices is the responsible and commonsense way to stand up to the industry’s greed – which, certain members of Congress should be reminded, lawmakers in both parties have been promising to do for years.”

“Millions of American families ration medicine to help pay the bills. Until now, the U.S. government has not even asserted power to help by negotiating more reasonable prices,” said Peter Maybarduk, director of Public Citizen’s Access to Medicines program. “Drug corporations clearly are taking advantage of that weakness, and abusing their monopoly privileges – and everyone in the U.S. is paying for it.”

Read the full report here.

###

Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people – not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.

AOC, Joyce Introduce Bipartisan Bill for 'Immediate Relief' From Cannabis Convictions

"Goes to show that lawmakers don't have to agree on everything to find common ground on solutions to the challenges facing everyday Americans."

Brett Wilkins ·


Green Groups Demand Answers About 'Flimsy' and Buried Biden Drilling Report

"Public records released as a result of this request will shine light on the dangerous chasm separating Biden's climate promises from his refusal to phase out the use of our public lands and waters for oil and gas extraction."

Jessica Corbett ·


'Protest Works': Cheers as Shell Signals Pullout of Cambo Oil Field Project

"We have to see the end of North Sea projects as well as all new fossil fuel extraction: There is no future in them."

Julia Conley ·


Pentagon Blasted for 'Unacceptable Failure' to Reckon With Civilian Casualties

"For too long, the United States has failed to live up to its legal and moral commitments to the protection of civilians, as well as its own stated policies. This needs to change."

Brett Wilkins ·


Groups Say Congress Should Reject Biden's Harmful Sentencing Proposal on Fentanyl-Related Drugs

"The facts don't support the argument that a harsh law enforcement approach, such as permanent classwide scheduling of fentanyl-related substances, will curb drug distribution, sale, and use."

Andrea Germanos ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo